HCP
BSX icon

Hexagon Capital Partners’s Boston Scientific BSX Stock Holding History

Hexagon Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$286K Buy
+4,561
New +$365K 0.04% 196
2025
Q2 		– Sell
-4,876
Closed -$492K – 298
2025
Q1 		$492K Buy
4,876
+114
+2% +$11.5K 0.09% 106
2024
Q4 		$425K Buy
4,762
+127
+3% +$11.2K 0.08% 119
2024
Q3 		$388K Sell
4,635
-49
-1% -$3.86K 0.08% 121
2024
Q2 		$361K Sell
4,684
-195
-4% -$14.3K 0.08% 131
2024
Q1 		$334K Sell
4,879
-140
-3% -$9K 0.07% 133
2023
Q4 		$290K Buy
5,019
+136
+3% +$7.26K 0.07% 146
2023
Q3 		$258K Sell
4,883
-30
-0.6% -$1.57K 0.07% 137
2023
Q2 		$266K Sell
4,913
-199
-4% -$10.4K 0.07% 133
2023
Q1 		$256K Sell
5,112
-450
-8% -$21.2K 0.07% 126
2022
Q4 		$257K Sell
5,562
-252
-4% -$10.9K 0.07% 127
2022
Q3 		$225K Sell
5,814
-1,130
-16% -$45.3K 0.07% 137
2022
Q2 		$259K Sell
6,944
-231
-3% -$9.4K 0.08% 143
2022
Q1 		$318K Hold
7,175
– – 0.08% 140
2021
Q4 		$305K Sell
7,175
-150
-2% -$6.3K 0.08% 138
2021
Q3 		$318K Sell
7,325
-643
-8% -$28.4K 0.09% 115
2021
Q2 		$341K Sell
7,968
-6,739
-46% -$284K 0.09% 109
2021
Q1 		$568K Sell
14,707
-3,659
-20% -$138K 0.16% 62
2020
Q4 		$660K Buy
18,366
+950
+5% +$34.2K 0.19% 48
2020
Q3 		$601K Buy
+17,416
New +$671K 0.19% 49

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hexagon Capital Partners's BSX Position: Q1 2026 in Review

Hexagon Capital Partners opened a new position in Boston Scientific (BSX) in Q1 2026: 4,561 shares worth $286K. The stake represents 0.04% of the portfolio and ranks #196 among its holdings. This is a return to the name: Hexagon Capital Partners previously reported a position in BSX as recently as Q1 2025.

Hexagon Capital Partners first reported a position in BSX in Q3 2020 and has held it in 20 quarters since. The position peaked at $660K in Q4 2020. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Hexagon Capital Partners held 4,561 shares of Boston Scientific worth $286K as of Q1 2026.
  • Boston Scientific was a new Hexagon Capital Partners position in Q1 2026.
  • Boston Scientific made up 0.04% of Hexagon Capital Partners's portfolio in Q1 2026, its #196 holding.
  • Hexagon Capital Partners first reported a position in Boston Scientific in Q3 2020 and has held it in 20 quarters since.
  • Hexagon Capital Partners's Boston Scientific position peaked at $660K in Q4 2020.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Hexagon Capital Partners's 13F filing for Q1 2026, filed 5 May 2026.